SOURCE: BIO-key International, Inc.
WALL, NJ--(Marketwired - Jan 2, 2014) - BIO-key International, Inc. (OTCQB: BKYI), a global leader in fingerprint biometric identification solutions, advanced mobile authentication and identity assurance technologies, today announced that Jim Skidmore, has joined BIO-key and has been appointed Senior Vice President of Global Sales.
"Jim Skidmore brings a deep understanding of technology, security and channel development to BIO-key," stated Mike DePasquale, BIO-key CEO. "We're extremely excited about incorporating Jim's talents along with his ability to extend BIO-key's partner footprint by leveraging his twenty plus years of existing business relationships, within the security industry. Most recently, as Vice President of Encode, a software and hardware reseller, Jim increased revenue from start-up to $7.5M in eighteen months and ultimately helped build a $20M business focused on identity and access management. We believe, based upon his leadership skills and industry knowledge that Jim can have a similar impact at BIO-key."
Before joining BIO-key, Jim was Vice President of the Solutions Group with Encode. Prior to that, he was Regional Vice President for Cotelligent a solutions integrator focused on CRM, Customer Loyalty, Mobility and Wireless Managed Solutions and Large Scale Integration. Previous to Cotelligent, Jim held several executive sales management positions all focused on implementation and integration of technology to increase security, meet compliance demands and improve workflow. Jim is a graduate of Susquehanna University and also participated in the IBM Executive Leadership Group at Duke University and is a member of IBM's Security Advisory Committee.
The IT and security industry are well aware of his past accomplishments; as demonstrated by the various awards Jim's received from IBM, Oracle/BEA, Microsoft, Blue Martini, ATG, and Evergreen.
Jim's responsibilities at BIO-key include driving revenue, managing, expanding and the further development of the sales team with a primary focus in identity and access management and the healthcare and market. Jim, will also manage the BIO-key sales partner network with the objective of leveraging his existing relationships and adding new ones to the channel.
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2012 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.